Recent advances in biomimetic cell membrane–camouflaged nanoparticles for cancer therapy - 23/07/24
Abstract |
The emerging strategy of biomimetic nanoparticles (NPs) via cellular membrane camouflage holds great promise in cancer therapy. This scholarly review explores the utilization of cellular membranes derived from diverse cellular entities; blood cells, immune cells, cancer cells, stem cells, and bacterial cells as examples of NP coatings. The camouflaging strategy endows NPs with nuanced tumor-targeting abilities such as self-recognition, homotypic targeting, and long-lasting circulation, thus also improving tumor therapy efficacy overall. The comprehensive examination encompasses a variety of cell membrane camouflaged NPs (CMCNPs), elucidating their underlying targeted therapy mechanisms and delineating diverse strategies for anti-cancer applications. Furthermore, the review systematically presents the synthesis of source materials and methodologies employed in order to construct and characterize these CMCNPs, with a specific emphasis on their use in cancer treatment.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Synthesis methods of CMCNPs discussed for advanced drug delivery in cancer area. |
• | Investigation of different CMs to address limitations of organic and inorganic NPs. |
• | Biomimetic NPs' diverse membrane functionalities and receptors reviewed. |
• | The potentials of CMCNPs in the treatment of cancer are summarized. |
Keywords : Biomimetic NPs, CMCNPs, Homotypic targeting, Drug delivery, Cancer therapy
Plan
| ☆ | Abbreviations NPs, EPR, CMCNPs, RES, RBCs,BM, MSCs,CMs, PBS, PLGA,UCNPs, PDI, GMP, TEM, RBCM, SDS-PAGE, PCL, MSNs, DOX, ICG, BBB, GN,IRN, PTM, HSA, PFTBA, MSNRs,MRI, CMC, RGD, PTX, MR, PTT, NK, CTLs, VCAM-1, CSF1R, GPCR, LFA-1, ICAM-1, NE, MHC, DNAM-1, NKG2D, PDGF/PDGFR, VEGF/VEGFR, PDA,CCAMs, EpCAM, PDL-1, Met, Cs, FGL1 OMV, HER2, SIRPα, ROS, PDT, APCs, TAAs, ICD, TME,CBA, DVDMS, CCM, MNC, US, GSNO, Ce6, Mn-MOF, PB, GBM,PA, NLS, GOX, SLNs, ECM |
Vol 177
Article 116951- août 2024 Retour au numéro
Article précédent
- Emerging insights into Lipocalin-2: Unraveling its role in Parkinson's Disease
- Ruqing Qiu, Yunjia Cai, Yana Su, Kangli Fan, Zhihui Sun, Ying Zhang
- Pharmacological insight of rutin as a potential candidate against peptic ulcer
- Sajidur Rahman Akash, Afrida Tabassum, Lamisa Manha Aditee, Abidur Rahman, Md Imran Hossain, Md. Abdul Hannan, Md Jamal Uddin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?